Analysts think SMLR stock price could increase by 6%
Jun 14, 2024, 6:27 AM
-10.10%
What does SMLR do
Semler Scientific, Inc., based in Santa Clara, California, specializes in technology and software solutions aimed at enhancing healthcare providers' effectiveness, primarily through its QuantaFlo product that diagnoses peripheral arterial disease. The company, which went public in 2014 and employs 127 people, also offers Insulin Insights software in the U.S. and Puerto Rico for managing insulin levels in Type 2 diabetes patients.
3 analysts think SMLR stock price will increase by 6.22%. The current median analyst target is $40.80 compared to a current stock price of $38.41. The lowest analysts target is $40.40 and the highest analyst target is $42.00.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.